高齢糖尿病患者に対するメトホルミン使用に関する薬物動態学的および薬力学的評価
スポンサーリンク
概要
- 論文の詳細を見る
Since the biguanide metformin lowers blood sugar levels in the absence of insulin secretion it should be useful for elderly patients with type 2 diabetes mellitus. In this study, the authors examined the pharmacokinetics, efficacy and safety of metformin in the elderly. All analyses were conducted on 86 outpatients given metformin hydrochloride tablets continuously. They were divided into two groups according to age : elderly group (age>=65, n=35) and non-elderly group (age<65, n=51). Creatinine clearance (CCr) was significantly lower in the elderly group than the non-elderly group (p<0.001). In 43 patients from whom plasma samples were collected 2-6 hours after taking metformin, the metformin concentration per dose (Cp/D) increased in pace with the decrease in CCr (Cp/D=3.00·CCr-0.595, r=0.413, p<0.001). On the other hand, in the same CCr group, there was no difference in Cp/D between the elderly and non-elderly patients. In 69 patients to whom metformin was newly prescribed, there was no correlation between patient age and decrease in Hemoglobin A1c (HbA1c). In patients with no hepatic dysfunction, the incidence of side effects in the elderly group was the same as that in non-elderly group (23.3% and 24.4%, respectively). In conclusion, since no difference in metformin pharmacokinetics, efficacy or safety was observed between the two patient groups, we consider that metformin is a useful drug for the elderly with normal renal and hepatic function.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)